Reducing lipids and resolving phlegm

"Reducing lipids and resolving phlegm" (known in Mandarin as Huatan Jiangzhi) is a fundamental therapeutic principle in Traditional Chinese Medicine (TCM) rather than a specific molecular target such as a receptor or enzyme. In the context of TCM, "phlegm" is a broad pathological concept that includes both visible mucus and "invisible" metabolic disturbances, which modern pharmacology often correlates with dyslipidemia and the buildup of atherosclerotic plaques. This principle is primarily employed to treat metabolic disorders, including hyperlipidemia, obesity, and atherosclerosis, by promoting the clearance of metabolic waste and restoring lipid homeostasis. While not a single target itself, research into formulas that "reduce lipids and resolve phlegm" has identified their effects on various validated biological targets, including HMG-CoA reductase, Peroxisome Proliferator-Activated Receptors (PPARs), and the AMPK signaling pathway. Because the term describes a pharmacological effect or a class of herbal actions rather than a discrete protein, it is classified as an incorrect target name for structured drug discovery databases. Analysts should instead look for specific molecular targets modulated by TCM herbs associated with this effect, such as those found in the Zexie Tang or Er Chen Tang formulas.

Other names

Huatan JiangzhiLipid-lowering and phlegm-resolvingPhlegm-transforming and lipid-reducingPhlegm-resolving and lipid-lowering

This is a therapeutic principle rather than a target; however, herbs with this action often function by activating AMPK, modulating PPAR-alpha/gamma, and inhibiting HMG-CoA reductase to regulate lipid profiles and reduce oxidative stress.